Technical Analysis for PFE - Pfizer, Inc.

Grade Last Price % Change Price Change
grade B 41.95 0.07% 0.03
PFE closed up 0.07 percent on Friday, May 24, 2019, on 64 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical PFE trend table...

Date Alert Name Type % Chg
Overbought Stochastic Strength 0.00%
Overbought Stochastic Strength 0.07%
Overbought Stochastic Strength -0.10%
Up 3 Days in a Row Strength -0.10%
Narrow Range Bar Range Contraction 0.67%
Overbought Stochastic Strength 0.67%
50 DMA Support Bullish 0.87%
MACD Bullish Centerline Cross Bullish 0.87%
Stochastic Reached Overbought Strength 0.87%
Inside Day Range Contraction 0.87%

Older signals for PFE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.
Health Biopharmaceutical Pharmaceutical Industry Pain Disease Medication Pharmaceutical Products Inflammation Neuroscience Alzheimer's Disease Pain Management Cnx Nifty Dietary Supplements Pulmonary Arterial Hypertension Major Depressive Disorder Hemophilia Anti Infectives Pfizer Erectile Dysfunction Glaxosmithkline Livestock Producers Cardiovascular Endocrine Disorders Lupin Limited Non Pharmaceutical Products
Is PFE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 46.47
52 Week Low 35.32
Average Volume 22,264,214
200-Day Moving Average 42.5304
50-Day Moving Average 41.4604
20-Day Moving Average 41.1385
10-Day Moving Average 41.461
Average True Range 0.6463
ADX 20.46
+DI 24.4723
-DI 12.7638
Chandelier Exit (Long, 3 ATRs ) 40.3711
Chandelier Exit (Short, 3 ATRs ) 41.1039
Upper Bollinger Band 42.3304
Lower Bollinger Band 39.9466
Percent B (%b) 0.84
BandWidth 5.794572
MACD Line 0.197
MACD Signal Line 0.0309
MACD Histogram 0.1661
Fundamentals Value
Market Cap 249.5 Billion
Num Shares 5.95 Billion
EPS 1.37
Price-to-Earnings (P/E) Ratio 30.62
Price-to-Sales 4.06
Price-to-Book 3.64
PEG Ratio 2.40
Dividend 1.28
Dividend Yield 3.05%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.61
Resistance 3 (R3) 42.66 42.48 42.50
Resistance 2 (R2) 42.48 42.32 42.46 42.46
Resistance 1 (R1) 42.22 42.21 42.13 42.17 42.43
Pivot Point 42.04 42.04 42.00 42.02 42.04
Support 1 (S1) 41.78 41.88 41.69 41.73 41.47
Support 2 (S2) 41.60 41.77 41.58 41.44
Support 3 (S3) 41.34 41.60 41.40
Support 4 (S4) 41.29